COVID-19 VACCINE LETHAL INJECTIONS

GLOBAL GENOCIDE

(Black Sun Bio-Weapons)

Sinovac
COVID-19 Vaccine

(Sinovac Biotech, CHINA)

The Official Story

CORONAVAC COVID-19 VACCINE
(Sinovac Biotech, CHINA)

CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was Phase III clinical trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), temperatures at which flu vaccines are kept.

A real-world study of tens of millions of Chileans who received CoronaVac found it 66% effective against symptomatic COVID-19, 88% against hospitalization, 90% against ICU admissions, and 86% against deaths. In Brazil, after 75% of the population in Serrana, São Paulo, received CoronaVac, preliminary results show deaths fell by 95%, hospitalizations by 86%, and symptomatic cases by 80%. In Indonesia, real world data from 128,290 healthcare workers showed 94% protection against symptomatic infection by the vaccine, beating results in clinical trials.

Phase III results from Turkey published in The Lancet showed an efficacy of 84% based on 10,218 participants in the trials. Phase III results from Brazil previously showed 50.7% efficacy at preventing symptomatic infections and 83.7% effective in preventing mild cases needing treatment. Efficacy against symptomatic infections increased to 62.3% with an interval of 21 days or more between the doses.

CoronaVac is being used in vaccination campaigns in various countries in Asia, South America, Central America, and Eastern Europe. By April 2021, Sinovac had a production capacity of 2 billion doses a year. It is currently being manufactured at several facilities in China, with planned overseas manufacture in Brazil in September 2021 and eventually in Egypt and Hungary.

On 1 June 2021, the World Health Organization (WHO) validated the vaccine for emergency use. Sinovac has signed purchase agreements for 380 million doses from COVAX. As of July 2021, CoronaVac was the most widely used COVID-19 vaccine in the world, with 943 million doses delivered.

As of 14 October 2021, CoronaVac is the COVID-19 vaccine with most doses administered worldwide.

A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of Medicine, The Chinese University of Hong Kong (CU Medicine) showed that a third dose of Comirnaty vaccine given to those who received two doses of either Comirnaty or CoronaVac provides protective levels of measured antibodies against the Omicron variant of SARS-CoV-2. Three doses of CoronaVac however did not provide adequate levels of protective antibodies by the same measure, in direct contradiction to claims made by the vaccine manufacturer.

Authorizations

The World Health Organization (WHO) validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use on 1 June 2021. The recommendation was given with limited evidence at the time of approval for groups other than healthy adults. The WHO Strategic Advisory Group of Experts expressed high level of confidence in the efficacy of the vaccine for adults, moderate confidence in the efficacy for older adults and individuals with comorbidities, moderate confidence in its safety for adults and low confidence in its safety for the elderly and individuals with comorbidities.

In late August 2020, China approved CoronaVac for emergency use to vaccinate high-risk groups such as medical staff. In early February, China approved CoronaVac for general use. On 5 June 2021, China approved CoronaVac for emergency use with children and adolescents for 3–17 years old.

In January 2021, Bolivia authorized use of CoronaVac.

In April, Panama approved emergency use of Coronavac.

On 4 May, the EMA’s human medicines committee (CHMP) started a rolling review of CoronaVac.

In June, Bangladesh approved Coronavac for emergency use.

Source: Wikipedia

BORG/AI ASSIMILATION

(Star Trek: First Contact, 1996)

WAKE UP — WE ARE HERE NOW

CoronaVac COVID-19 Vaccine

The CoronaVac COVID-19 vaccine is an inactivated virus vaccine produced by the Chinese company Sinovac Biotech.

CoronaVac Worldwide Authorizations

GLOBAL GENOCIDE 2025 (Click Links Below)

Full (1)

China

Emergency (79)

Non-country entities

Hong Kong
Northern Cyprus
World Health Organization

Travel-only

Andorra
Australia
Austria (only for entry)
Canada
Costa Rica
Croatia
Cyprus
Estonia (only if approved in a person’s country of origin)
Finland
Greece
Grenada
Iceland
Ireland
Japan
Liechtenstein
Netherlands
New Zealand
Norway
Palau
Panama
Portugal (only in Madeira)
Slovakia
Slovenia
South Korea
Spain
St. Kitts and Nevis
St. Lucia
St. Vincent and the Grenadines
Sweden
Switzerland
Ukraine
United Arab Emirates
United Kingdom
United States
Vietnam

CRIMES AGAINST HUMANITY — NUREMBERG II

The Truth

FALSE FLAG

A false flag is a covert operation designed to deceive; the deception creates the appearance of a particular party, group, or nation being responsible for some activity, disguising the actual source of responsibility.

SUBLIMINAL
adjective

(of a stimulus or mental process) below the threshold of sensation or consciousness; perceived by or affecting someone’s mind without their being aware of it.

YOU KNOW WHAT TIME IT IS…

COVID-19 TRUTH

HISTORICAL TRUTH

HOLOCAUST TRUTH

THE HOLOCAUST
The mass murder of Jews under the German Nazi regime during the period 1941–5. More than 6 million European Jews, as well as members of other persecuted groups, were murdered at concentration camps such as Auschwitz.